3D interface 3D-MIND: connecting electronics with brain cells https://ymaho.com/3d-interface-3d-mind-connecting-electronics-with-brain-cells
Princeton scientists created 3D-MIND — a flexible neurointerface for integrating neurons with electronics. Learn how the technology opens the way to biocomputers and disease treatment. Read the analysis.
Psychodermatology 2026: cosmetics for stress and nerves https://ymaho.com/psychodermatology-2026-cosmetics-for-stress-and-nerves
Creams with neuro-effects that reduce cortisol and activate the vagus. 60% of acne and eczema are caused by stress. Find out how La Roche-Posay and Shiseido create care that manages the brain through the skin.
Nanovesicles break the stress-tumor connection: Nature https://ymaho.com/nanovesicles-break-the-stress-tumor-connection-nature
Biomimetic nanovesicles block neuro-tumor dialogue and increase chemotherapy efficacy by 70%. Learn how stress affects cancer and what the new platform changes. Read the detailed analysis.
FDA agreed on trial design for Privosegtor in optic neuritis https://ymaho.com/fda-agreed-on-trial-design-for-privosegtor-in-optic-neuritis
FDA approved the design of registration trials for the neuroprotector Privosegtor for the treatment of optic neuritis. Learn how the drug can change neuro-ophthalmology and what prospects the SPA agreement opens.
AI predicts meningioma recurrence without genetics — 2026 analysis https://ymaho.com/ai-predicts-meningioma-recurrence-without-genetics-2026-analysis
Mayo Clinic created AI analyzing tumor slides to predict meningioma recurrence without DNA methylation. Accuracy comparable to genetics. Learn how this changes neuro-oncology.
Breakthrough in glioblastoma treatment: NeoVax vaccine improves survival | ASCO 2026 https://ymaho.com/breakthrough-in-glioblastoma-treatment-neovax-vaccine-improves-survival-asco-2026
Dana-Farber's personalized vaccine NeoVax showed median survival of 36.9 months in glioblastoma at ASCO 2026. Learn how immunotherapy works and who it suits.
AI predicts brain cancer without biopsy using PET/CT https://ymaho.com/ai-predicts-brain-cancer-without-biopsy-using-pet-ct
Multimodal AI model based on graph neural networks analyzes PET/CT and predicts glioma mutations with >95% accuracy. Non-invasive diagnosis without biopsy. Learn more.
Neuron transplantation in stroke: a breakthrough in mice https://ymaho.com/neuron-transplantation-in-stroke-a-breakthrough-in-mice
Scientists transplanted human neurons into mice and launched brain recovery after stroke. Find out why this is not just a patch, but a system reboot. Read the analysis.
ATF2 gene: key CRISPR target for neuron rescue https://ymaho.com/atf2-gene-key-crispr-target-for-neuron-rescue
Neuron study: CRISPR knockout of ATF2 gene prevents neuron death during chemotherapy, ALS, and glaucoma. Analysis of a breakthrough in neuroprotection. Learn more.